Medality Medical (former Andrew Technologies) Company
.png)
Andrew Technologies, LLC, is a medical technology company with a proprietary surgical innovation called Tissue Liquefaction Technology:tm:. The first product to utilize TLT was launched in 2003 by Alcon for cataract surgery. In 2012, the FDA cleared HydraSolve:registered: Lipoplasty System. Andrew Technologies also has an impressive research pipeline focused on stem cells and diabetes.
Industry:
Geroscience
Headquarters:
Tustin, California, United States
Zip:
1-10
Founded Date:
2007-01-01
Employees Number:
1-10
Investors Number:
24861769
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
info@andrew-technologies.com
Register and Claim Ownership